<DOC>
	<DOC>NCT02064530</DOC>
	<brief_summary>the aim of this study is evaluate postoperative analgesic effects of dexmedetomidine added to bupivacaine on TAP block in patients undergoing lower abdominal surgery.</brief_summary>
	<brief_title>Postoperative Analgesic Effects of Dexmedetomidine for Transversus Abdominis Plane Block</brief_title>
	<detailed_description>TAP block is being used a method of multimodal balanced analgesia reduces postoperative pain, opioid requirement after surgery and adverse effect of opioid such as sedation, nausea vomiting and ileus. Dexmedetomidine ,an alfa-2 adrenoreceptor agonist, is being used and adjuvant capable of prolonging duration of sensory and motor block on nerve blocks.</detailed_description>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>ASA 12 1865 aged patient undergoing lower abdominal surgery chronic opioid consumption bupivacaine and dexmedetomidine allergies coagulopathy infection at the needle insertion side chronic liver and kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>TAP block</keyword>
	<keyword>dexmedetomidine</keyword>
	<keyword>bupivacaine</keyword>
	<keyword>postoperative analgesia</keyword>
</DOC>